Research ArticleClinical Studies
Alcohol and HER2 Polymorphisms as Risk Factor for Cardiotoxicity in Breast Cancer Treated with Trastuzumab
JULIE LEMIEUX, CAROLINE DIORIO, MARC-ANDRÉ CÔTÉ, LOUISE PROVENCHER, FRÉDÉRIC BARABÉ, SIMON JACOB, CHRISTINE ST-PIERRE, ÉRIC DEMERS, ROSEMARIE TREMBLAY-LEMAY, CORINNE NADEAU-LAROCHELLE, ANNICK MICHAUD and CHRISTIAN LAFLAMME
Anticancer Research June 2013, 33 (6) 2569-2576;
JULIE LEMIEUX
1Oncology Axis, CHU of Quebec Research Center, Quebec City, QC, Canada
2Deschênes-Fabia Center for Breast Diseases, Saint-Sacrement Hospital, Quebec City, QC, Canada
3Quebec City Hematology and Oncology University Center, Quebec City, QC, Canada
4Faculty of Medicine, Laval University, Quebec City, QC, Canada
CAROLINE DIORIO
1Oncology Axis, CHU of Quebec Research Center, Quebec City, QC, Canada
2Deschênes-Fabia Center for Breast Diseases, Saint-Sacrement Hospital, Quebec City, QC, Canada
4Faculty of Medicine, Laval University, Quebec City, QC, Canada
MARC-ANDRÉ CÔTÉ
2Deschênes-Fabia Center for Breast Diseases, Saint-Sacrement Hospital, Quebec City, QC, Canada
4Faculty of Medicine, Laval University, Quebec City, QC, Canada
LOUISE PROVENCHER
1Oncology Axis, CHU of Quebec Research Center, Quebec City, QC, Canada
2Deschênes-Fabia Center for Breast Diseases, Saint-Sacrement Hospital, Quebec City, QC, Canada
4Faculty of Medicine, Laval University, Quebec City, QC, Canada
FRÉDÉRIC BARABÉ
3Quebec City Hematology and Oncology University Center, Quebec City, QC, Canada
4Faculty of Medicine, Laval University, Quebec City, QC, Canada
5Research Center in Infectious Diseases, CHU Research center, Quebec City, QC, Canada
SIMON JACOB
1Oncology Axis, CHU of Quebec Research Center, Quebec City, QC, Canada
2Deschênes-Fabia Center for Breast Diseases, Saint-Sacrement Hospital, Quebec City, QC, Canada
CHRISTINE ST-PIERRE
1Oncology Axis, CHU of Quebec Research Center, Quebec City, QC, Canada
2Deschênes-Fabia Center for Breast Diseases, Saint-Sacrement Hospital, Quebec City, QC, Canada
ÉRIC DEMERS
1Oncology Axis, CHU of Quebec Research Center, Quebec City, QC, Canada
ROSEMARIE TREMBLAY-LEMAY
2Deschênes-Fabia Center for Breast Diseases, Saint-Sacrement Hospital, Quebec City, QC, Canada
CORINNE NADEAU-LAROCHELLE
1Oncology Axis, CHU of Quebec Research Center, Quebec City, QC, Canada
ANNICK MICHAUD
1Oncology Axis, CHU of Quebec Research Center, Quebec City, QC, Canada
CHRISTIAN LAFLAMME
1Oncology Axis, CHU of Quebec Research Center, Quebec City, QC, Canada
2Deschênes-Fabia Center for Breast Diseases, Saint-Sacrement Hospital, Quebec City, QC, Canada
In this issue
Alcohol and HER2 Polymorphisms as Risk Factor for Cardiotoxicity in Breast Cancer Treated with Trastuzumab
JULIE LEMIEUX, CAROLINE DIORIO, MARC-ANDRÉ CÔTÉ, LOUISE PROVENCHER, FRÉDÉRIC BARABÉ, SIMON JACOB, CHRISTINE ST-PIERRE, ÉRIC DEMERS, ROSEMARIE TREMBLAY-LEMAY, CORINNE NADEAU-LAROCHELLE, ANNICK MICHAUD, CHRISTIAN LAFLAMME
Anticancer Research Jun 2013, 33 (6) 2569-2576;
Alcohol and HER2 Polymorphisms as Risk Factor for Cardiotoxicity in Breast Cancer Treated with Trastuzumab
JULIE LEMIEUX, CAROLINE DIORIO, MARC-ANDRÉ CÔTÉ, LOUISE PROVENCHER, FRÉDÉRIC BARABÉ, SIMON JACOB, CHRISTINE ST-PIERRE, ÉRIC DEMERS, ROSEMARIE TREMBLAY-LEMAY, CORINNE NADEAU-LAROCHELLE, ANNICK MICHAUD, CHRISTIAN LAFLAMME
Anticancer Research Jun 2013, 33 (6) 2569-2576;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Chemotherapy-Related Cardiac Dysfunction: A Systematic Review of Genetic Variants Modulating Individual Risk
- Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis
- HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women
- HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women
- Cardiac Surveillance Findings During Adjuvant and Palliative Trastuzumab Therapy in Patients with Breast Cancer